The effects of ceramide regulated bone morphogenetic protein 3 on adipocyte metabolism
Abstract
Details
- Title: Subtitle
- The effects of ceramide regulated bone morphogenetic protein 3 on adipocyte metabolism
- Creators
- Aaron Tran
- Contributors
- Bhagirath Chaurasia (Advisor)Vitor Lira (Committee Member)Gary Pierce (Committee Member)
- Resource Type
- Thesis
- Degree Awarded
- Master of Science (MS), University of Iowa
- Degree in
- Health and Human Physiology
- Date degree season
- Spring 2024
- Publisher
- University of Iowa
- DOI
- 10.25820/etd.007341
- Number of pages
- viii, 25 pages
- Copyright
- Copyright 2024 Aaron Tran
- Language
- English
- Date submitted
- 04/17/2024
- Description illustrations
- color illustrations
- Description bibliographic
- Includes bibliographical references (page 24-25).
- Public Abstract (ETD)
Obesity is responsible for the development of various metabolic diseases like type 2 diabetes and heart disease, costing the US healthcare system $147 billion a year. The consumption of more food or nutrients than the body needs leads to increased fat accumulation in the body. This increased fat accumulation is harmful and can lead to the production of toxic lipid metabolites. Some of the most harmful toxic lipid metabolites produced under conditions of excess nutrition are called ceramides. Ceramides have been linked to the development of various heart diseases and cancers. We have found a new protein in the body that we believe is controlled by ceramides and it is called Bone Morphogenetic Protein 3 (Bmp3). Bmp3 is significantly reduced in fat tissues when we inhibit ceramides, and it is significantly elevated with the increase in ceramides. With these findings, we are confident in our identification of Bmp3 as a ceramide-regulated transcript. In this study, we plan to better understand the role of Bmp3 in obesity and insulin resistance.
- Academic Unit
- Health and Human Physiology
- Record Identifier
- 9984647256802771